Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on March 11, 2002, primarily to disclose upcoming meetings with securities analysts and investors scheduled for the week of March 11, 2002. During these meetings, company officers intended to reaffirm their ability to meet previously issued earnings expectations. These expectations were initially communicated through a press release and conference call on February 6, 2002, a copy of which was also filed with the SEC.
Key Highlights
- 1Company officers to meet with analysts and investors during the week of March 11, 2002.
- 2Management expects to confirm the ability to meet prior earnings expectations.
- 3Earnings expectations were initially set on February 6, 2002, via press release and conference call.
- 4The filing refers to forward-looking statements and associated risks and uncertainties.
- 5Identified risks include healthcare cost trends, premium rate increases, competitor actions, government regulation, new drug/technology introduction, financial strength ratings, litigation, provider contracting, and economic downturns.
Frequently Asked Questions
The primary purpose of this 8-K filing is to inform investors and the public that Elevance Health (then Anthem, Inc.) executives were scheduled to meet with securities analysts and investors and to reiterate their confidence in meeting previously stated earnings expectations.
The earnings expectations were initially communicated to the public through a press release and conference call on February 6, 2002.
The company acknowledges a range of risks, including fluctuations in healthcare costs and utilization, the ability to secure adequate premium rate increases, competitive pricing pressures, increased government regulation, strategic moves by competitors, the impact of new medical technologies and drugs, changes in financial strength ratings, potential litigation, challenges in provider contracting, and general economic conditions.
No, this 8-K filing does not provide updated financial results. Its main focus is on management's intent to reaffirm existing earnings guidance and the associated forward-looking statements and risks.